Eyeing the Options for Treating Meibomian Gland Dysfunction and Dry Eye Disease

1.00 CME
60 MINS
$0 FEE
SAVE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Eyeing the Options for Treating Meibomian Gland Dysfunction and Dry Eye Disease

Overview

Provider Statement

This continuing education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by an educational grant from Bausch + Lomb.

Activity Description

Dry eye disease (DED) is highly prevalent but frequently underdiagnosed and subsequently undertreated. Studies have demonstrated that meibomian gland dysfunction (MGD) is a leading cause of the development and progression of evaporative DED, caused by a deficient tear film lipid layer that leads to increased tear evaporation. New and emerging treatments with novel mechanisms of action are being investigated that manage the signs and symptoms of DED associated with MGD and offer the potential for improved quality of life and greater preservation of vision. In this continuing education monograph, experts in the field review the pathophysiology, burden, and risk factors associated with DED and MGD and assess the efficacy and safety of current and emerging therapies.

Target Audience

The intended audience for this activity is ophthalmologists, optometrists, and other health care professionals responsible for the overall management of patients with, or at risk for, dry eye disease and meibomian gland dysfunction.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Summarize the pathophysiology, burden, and risk factors associated with dry eye disease (DED) and meibomian gland dysfunction (MGD).
  • Assess the efficacy and safety of current and emerging DED and MGD.

Activity Chair

Alice T. Epitropoulos, MD, FACS
Ophthalmic Surgeons and Consultants of Ohio
The Eye Center of Columbus
Clinical Assistant Professor
The Ohio State University Medical Center
Columbus, OH

Faculty

Jennifer M. Loh, MD
Medical Director, Loh Ophthalmology Associates
Board Member, Eye Physicians of Florida
Clinical Faculty, Larkin Hospital Ophthalmology Residency
Miami, FL

Planner/Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Medical Writer

Valerie Zimmerman, PhD

Accreditation

ACCME Jointly accredited In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, May 31, 2023, to May 30, 2024.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 of the 10 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

The articles in this monograph were composed by Medical Writer Valerie Zimmerman, PhD based on the presentations of Drs. Epitropoulos and Loh at a live expert panel held on February 17, 2023. The monograph has been approved by both of the faculty individually as an accurate representation of their presentations.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

Alice T. Epitropoulos, MD, FACS
Employee or Executive Role: Physician Recommended Nutriceuticals*
Royalties or Patent Beneficiary: Hilco
Advisor: Oyster Point
Consultant: Aldeyra, Allergan/AbbVie, Bausch + Lomb, BioTissue, Bruder, Dompé, EyePoint, Imprimis, Johnson & Johnson Vision, Novartis, Ocular Therapeutix, Physician Recommended Nutriceuticals, Sun, Tarsus, Visus, Zeiss
Speaker Contracted by Ineligible Company: Allergan/AbbVie, Bausch + Lomb, Dompé, Johnson & Johnson Vision, Ocular Therapeutix, Oyster Point, Sun
Independent Research Contractor: Bausch + Lomb, Sylentis

Jennifer M. Loh, MD
Consultant: Alcon, Allergan, Bausch + Lomb, Centricity Vision, Horizon, Johnson & Johnson Vision, Kala, LENSAR, Novartis, Omeros, Orasis, OSRX, Sight Sciences, Sun, Tarsus, Visus, Zeiss
Speaker Contracted by Ineligible Company: Allergan, Kala, Sight Sciences, Sun
Independent Research Contractor: Sight Sciences
Individual Stocks and Stock Options: NovaBay

*This activity is not related to the business lines or products of the employer.

Planner/Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Medical Writer reports the following relevant financial relationship(s)

Valerie Zimmerman, PhD
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CE Questions?

Contact us at cme@vindicoCME.com